Insulin resistance and altered glucose transporter 4 expression in experimental uremia
Aksentijević, Dunja; Bhandari, Sunil; Seymour, Anne Marie L
Anne Marie L Seymour
Progressive ventricular hypertrophy can lead to the development of insulin resistance, a feature of both chronic kidney disease and heart failure. Here we induced uremia in adult male Sprague-Dawley rats using a remnant kidney model and studied the expression of glucose transporters. As expected, the reduction of nephron mass resulted in impaired renal function, cardiac hypertrophy, glucose intolerance, hyperinsulinemia, anemia, and hypertension. Insulin sensitivity was significantly reduced in the uremic animals as determined by oral glucose tolerance tests. After six weeks of uremia, at a point when cardiac hypertrophy had been established, left ventricle tissue had a marked increase in the expression of GLUT4 (insulin-dependent glucose transporter 4), consistent with hypertrophic remodeling, but not GLUT1 (insulin-independent glucose transporter 1). However, although uremic animals had systemic insulin resistance and glucose intolerance, there was no evidence of impaired GLUT4 translocation in the heart at 6 weeks of uremia, suggesting that other mechanisms may underpin insulin resistance in the uremic heart.
Aksentijević, D., Bhandari, S., & Seymour, A. M. L. (2009). Insulin resistance and altered glucose transporter 4 expression in experimental uremia. Kidney International, 75(7), (711-718). doi:10.1038/ki.2008.691. ISSN 0085-2538
|Journal Article Type||Article|
|Deposit Date||Nov 13, 2014|
|Peer Reviewed||Peer Reviewed|
You might also like
Uremic cardiomyopathy and insulin resistance: a critical role for Akt?
Functional and metabolic adaptation in uraemic cardiomyopathy
Western diet impairs metabolic remodelling and contractile efficiency in cardiac hypertrophy
Compensated cardiac hypertrophy is characterised by a decline in palmitate oxidation